Cognitive-behavioral therapy for patients with post-COVID-19 condition (CBT-PCC) : a feasibility trial
BACKGROUND: The post-COVID-19 condition describes the persistence or onset of somatic symptoms (e.g. fatigue) after acute COVID-19. Based on an existing cognitive-behavioral treatment protocol, we developed a specialized group intervention for individuals with post-COVID-19 condition. The present study examines the feasibility, acceptance, and effectiveness of the program for inpatients in a neurological rehabilitation setting.
METHODS: The treatment program comprises eight sessions and includes psychoeducational and experience-based interventions on common psychophysiological mechanisms of persistent somatic symptoms. A feasibility trial was conducted using a one-group design in a naturalistic setting. N = 64 inpatients with a history of mild COVID-19 that fulfilled WHO criteria for post-COVID-19 condition were enrolled. After each session, evaluation forms were completed and psychometric questionnaires on somatic and psychopathological symptom burden were collected pre- and post-intervention.
RESULTS: The treatment program was well received by participants and therapists. Each session was rated as comprehensible and overall satisfaction with the sessions was high. Pre-post effect sizes (of standard rehabilitation incl. new treatment program; intention-to-treat) showed significantly reduced subjective fatigue (p < 0.05, dav = 0.33) and improved disease coping (ps < 0.05, dav = 0.33-0.49).
CONCLUSIONS: Our results support the feasibility and acceptance of the newly developed cognitive-behavioral group intervention for individuals with post-COVID-19 condition. Yet, findings have to be interpreted cautiously due to the lack of a control group and follow-up measurement, the small sample size, and a relatively high drop-out rate.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:54 |
|---|---|
| Enthalten in: |
Psychological medicine - 54(2024), 6 vom: 21. März, Seite 1122-1132 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Huth, Daniel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical Trial |
|---|
| Anmerkungen: |
Date Completed 15.03.2024 Date Revised 22.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1017/S0033291723002921 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363355774 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363355774 | ||
| 003 | DE-627 | ||
| 005 | 20240323234712.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/S0033291723002921 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1342.xml |
| 035 | |a (DE-627)NLM363355774 | ||
| 035 | |a (NLM)37842765 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Huth, Daniel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cognitive-behavioral therapy for patients with post-COVID-19 condition (CBT-PCC) |b a feasibility trial |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.03.2024 | ||
| 500 | |a Date Revised 22.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: The post-COVID-19 condition describes the persistence or onset of somatic symptoms (e.g. fatigue) after acute COVID-19. Based on an existing cognitive-behavioral treatment protocol, we developed a specialized group intervention for individuals with post-COVID-19 condition. The present study examines the feasibility, acceptance, and effectiveness of the program for inpatients in a neurological rehabilitation setting | ||
| 520 | |a METHODS: The treatment program comprises eight sessions and includes psychoeducational and experience-based interventions on common psychophysiological mechanisms of persistent somatic symptoms. A feasibility trial was conducted using a one-group design in a naturalistic setting. N = 64 inpatients with a history of mild COVID-19 that fulfilled WHO criteria for post-COVID-19 condition were enrolled. After each session, evaluation forms were completed and psychometric questionnaires on somatic and psychopathological symptom burden were collected pre- and post-intervention | ||
| 520 | |a RESULTS: The treatment program was well received by participants and therapists. Each session was rated as comprehensible and overall satisfaction with the sessions was high. Pre-post effect sizes (of standard rehabilitation incl. new treatment program; intention-to-treat) showed significantly reduced subjective fatigue (p < 0.05, dav = 0.33) and improved disease coping (ps < 0.05, dav = 0.33-0.49) | ||
| 520 | |a CONCLUSIONS: Our results support the feasibility and acceptance of the newly developed cognitive-behavioral group intervention for individuals with post-COVID-19 condition. Yet, findings have to be interpreted cautiously due to the lack of a control group and follow-up measurement, the small sample size, and a relatively high drop-out rate | ||
| 650 | 4 | |a Clinical Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a cognitive-behavioral therapy | |
| 650 | 4 | |a fatigue | |
| 650 | 4 | |a feasibility trial | |
| 650 | 4 | |a neurological rehabilitation | |
| 650 | 4 | |a persistent somatic symptoms | |
| 650 | 4 | |a post-COVID-19 condition | |
| 700 | 1 | |a Bräscher, Anne-Kathrin |e verfasserin |4 aut | |
| 700 | 1 | |a Tholl, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Fiess, Johanna |e verfasserin |4 aut | |
| 700 | 1 | |a Birke, Gunnar |e verfasserin |4 aut | |
| 700 | 1 | |a Herrmann, Christoph |e verfasserin |4 aut | |
| 700 | 1 | |a Jöbges, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Mier, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a Witthöft, Michael |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Psychological medicine |d 1970 |g 54(2024), 6 vom: 21. März, Seite 1122-1132 |w (DE-627)NLM000076112 |x 1469-8978 |7 nnns |
| 773 | 1 | 8 | |g volume:54 |g year:2024 |g number:6 |g day:21 |g month:03 |g pages:1122-1132 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1017/S0033291723002921 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 54 |j 2024 |e 6 |b 21 |c 03 |h 1122-1132 | ||